ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer. [electronic resource]
Producer: 20140317Description: 4273-81 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Aged, 80 and over
- Anaplastic Lymphoma Kinase
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Crizotinib
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- genetics
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Rearrangement
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Male
- Middle Aged
- Mutation
- Protein Kinase Inhibitors -- administration & dosage
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- Pyrazoles -- administration & dosage
- Pyridines -- administration & dosage
- Receptor Protein-Tyrosine Kinases
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.